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Detection of Pneumocystis carinii sequences in serum 
by polymerase chain reaction 
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J. TAKAHARA* 
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Japan 
The clinical significance of the detection of Pneumocystis carinii DNA was evaluated, as well as the detection 
of circulating P. carinii antigen from serum using previously collected samples. Fourteen serum samples from 
13 patients were diagnosed positively for P. carinii DNA by polymerase chain reaction (PCR). Ten of 14 
episodes (71.4%) of pulmonary complications were compatible with P. carinii pneumonia. Two patients were 
definitely diagnosed as having had P. carinii pneumonia at autopsy. All patients positive for circulating 
antigens were also positive for P. carinii DNA, suggesting that the detection of P. carinii DNA by PCR is 
more sensitive compared to the detection of circulating antigens by the Ouchterlony method. It is concluded 
that the detection of P. carinii DNA in serum by PCR provides useful information for identifying P. carinii 
pneumonia. 
Introduction 
Pneumocystis carinii (P. carinii) is an opportunis- 
tic pathogen which often causes severe and fatal 
pneumonia in immunocompromised patients. How- 
ever, in the early stages of infection, patients can be 
treated successfully with effective agents against 
P. carinii, for example, sulphamethoxazole- 
trimethoprim and/or pentamidine. Therefore, it is 
very important to establish a highly sensitive, highly 
specific, widely applicable, and non-invasive diagnos- 
tic method to detect P. carinii infection. 
Bronchoscopy with bronchoalveolar lavage or 
biopsy is currently the method employed frequently to 
establish the diagnosis (1). In addition, examination of 
induced sputum is potentially a rapid, non-invasive 
method of diagnosing P. carinii pneumonia (2,3). 
DNA amplification by the polymerase chain reac- 
tion (PCR) offers a sensitive and specific means of 
identifying diverse organisms which may be present 
in biological samples. Amplification of ribosomal 
RNA genes has been shown to be useful in increasing 
the sensitivity of detection of P. carinii DNA from 
sputum and bronchoalveolar lavage fluid (4-7). 
However, reports of the diagnosis of P. carinii 
infection using serum samples have been limited 
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(6,8,9). This study attempted to evaluate the clinical 
significance of the detection of P. carinii DNA as well 
as the detection of circulating P. carinii antigens from 
serum using previously collected samples. 
Materials and Methods 
PATIENTS 
From January 1991 to December 1994, serum 
samples were collected prospectively from patients 
with pulmonary complications. During this period, 
470 patients who had diseases associated with the risk 
of P. carinii infection were admitted to the authors’ 
department. Fifty-six sera (from 55 patients, 11.7%) 
were collected from patients with acute leukaemia, 
lymphoma, collagen vascular diseases, multiple 
myeloma, lung cancer, congenital immunodeficiency, 
haematological disorders, and from immature 
infants. All had pulmonary infiltrations such as inter- 
stitial, alveolar or mixed pattern as demonstrated on 
chest X-rays. This study attempted to detect P. carinii 
DNA in these samples using PCR in addition to 
screening to detect circulating P. carinii antigen using 
the Ouchterlony technique. 
DNA PREPARATION, AMPLIFICATION AND DETECTION (8) 
Serum (10~1) was incubated at 60°C for 6 h in a 
solution (20~1) containing 10 mM Tris-HCL (pH 
8.3) 50 mM KCI, 1.5 mM MgCl,, 0.5 mg gelatin, 
0.25% Nodidet P-40, 0.25% Tween-20, and 10 pug of 
proteinase K. The samples were boiled for 10 min 
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Plate I Detection of Pneumocystis carinii DNA by polymerase chain reaction and Southern blot analysis. The amplified 
products were confirmed as P. carinii DNA by Southern blot analysis using a labelled fragment of the ferret P. carinii gene 
as a probe. Lane Nos 0 and 11: control DNA (120 base pairs); Lanes l-10: serum samples. Lane Nos 1 and 6 were diagnosed 
as negative. 
and 10~1 of the supematant was used directly for 
PCR reaction. The 5S rRNA sequence of P. carinii 
was amplified by PCR in a reaction mixture (100 ~1) 
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 
1.5 mM MgCl,, 1 mg gelatin, 200~~ each deoxy- 
ribonucleotide triphosphate, 2.5 U of Taq DNA 
polymerase (Perkin Elmer Cetus), 50pmol each of 
SS-sense and SS-antisense primers and 10 ~1 of DNA 
solution. The primers were SS-sense (5’-AGTT 
ACGGCCATACCTCAGA-3’) and SS-antisense (5’- 
AAAGCTACAGCACGTCGTAT-3’), generating a 
120-bp (base pairs) product by PCR. Amplification 
was performed in a thermal cycler (Perkin Elmer 
Cetus) with a three-step cycling programme: 1 min of 
denaturation at 94°C followed by 2 min of annealing 
at 55°C and 2 min of elongation at 72°C for a total of 
40 cycles. The amplified products were subjected to 
electrophoresis through 10/20% polyacrylamide gels 
and the specific P. carinii sequence (120-bp) was 
identified by visualization with ultraviolet light after 
ethidium bromide staining. The results were con- 
firmed for P. carinii DNA by Southern blot analysis 
using a labelled fragment of the ferret P. carinii gene 
as a probe (8). 
DETECTION OF CIRCULATING ANTIGENS 
Pure antigens were first prepared from the lung 
tissue of rates infected with P. carinii, and a rabbit 
was sensitized with the antigen to induce anti- 
P. carinii antibody production. Rat sera containing 
antigenic substances then reacted with this antibody 
when examined by the Ouchterlony technique or 
immunoelectrophoresis as reported previously 
(10,ll). 
Results 
Fifty-six samples were examined out of 55 patients 
who had respiratory complications. Fourteen serum 
samples (14/56, 25%) from 13 patients (13/55, 23.6%) 
[one patient (Patient No. 11) provided two samples 
from two episodes of respiratory complications 
during this period] were positive for P. carinii DNA. 
Plate 1 shows the results of PCR and Southern blot 
in selected samples. Table 1 shows patient character- 
istics of those positive for P. carinii DNA as shown 
by PCR and/or positive for circulating antigens. Nine 
of 14 samples were also positive for circulating 
P. carinii antigens. 
Ten of 14 episodes (71.4%) of pulmonary compli- 
cations were compatible with P. carinii pneumonia. 
Two patients were definitely diagnosed as having had 
P. carinii pneumonia at autopsy (Patient Nos. 10 and 
13). Probable P. carinii pneumonia (Patient Nos. 1,3, 
4, 6, 7, 9, 11 and 12) was determined by chest X-ray 
findings (interstitial shadow) and a good response 
to sulphamethoxazole-trimethoprim. In four epi- 
sodes (Patient Nos. 2, 5, 8 and 1 l), although P. carinii 
infection was suggested clinically, a definite diagnosis 
was not obtained because an autopsy was not 
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performed. Interestingly, all patients who were posi- 
tive for circulating antigens were also positive for 
P. carinii DNA, suggesting that the detection of 
P. carinii DNA by PCR is a more sensitive indicator 
than the detection of circulating antigen by the 
Ouchterlony method. In addition, one patient 
(Patient No. 13) who was proved to have P. carinii 
infection at autopsy, was negative for circulating 
P. carinii antigens, also suggesting the possibility that 
the PCR method is more sensitive than the circulat- 
ing antigen assay for the diagnosis of P. carinii 
pneumonia. Furthermore, in Patient No. 3, although 
circulating antigens were not detected (circulating 
antigens became positive 1 week later), P. carinii 
DNA was detected even at the onset of the pul- 
monary complication, suggesting that the detection 
of P. carinii DNA by PCR is useful for the early 
diagnosis of P. carinii pneumonia. 
Patients who had negative results of P. carinii 
DNA by PCR were not clinically diagnosed as 
having P. carinii pneumonia. 
Discussion 
The present study analysed the significance of 
the detection of serum P. carinii DNA as well as the 
detection of circulating antigen using previously col- 
lected serum samples at the onset of pulmonary 
complications. Fourteen serum samples from 13 
patients were diagnosed positively for P. carinii DNA 
by polymerase chain reaction (PCR). Ten of 14 
episodes (71.4%) of pulmonary complications were 
compatible with P. carinii pneumonia. All patients 
positive for circulating antigens were also positive for 
P. carinii DNA, suggesting that the detection of 
P. carinii DNA by PCR is more sensitive compared 
to the detection of circulating antigens by the 
Ouchterlony method. 
It has been shown that P. carinii antigens are 
present in serum from patients with P. carinii pneu- 
monia and are potentially useful for the early diag- 
nosis of P. carinii pneumonia (10,ll). Pifer et al. 
reported that positive circulating antigen results were 
obtained from 95% of fresh serum samples and 62% 
of frozen serum samples of the patients proven to 
have P. carinii pneumonia by lung aspiration (10). 
However, detection of circulating P. carinii antigens 
in serum requires complicated techniques, and is 
difficult to apply widely. 
Conventional diagnosis of P. carinii pneumonia 
has usually been based on pathologic examination of 
appropriately stained tissue obtained via techniques 
of transbronchial biopsy, percutaneous lung biopsy, 
or open lung biopsy. The diagnostic yield of the 
procedures is variable, and complications are inher- 
ent, especially in the setting of profound hypoxaemia 
and bleeding diatheses (1). Bronchoalveolar lavage is 
a low morbidity procedure that has been used to 
diagnose P. carinii pneumonia in patients with lym- 
phoproliferative disorders and acquired immuno- 
deficiency syndrome (1). In addition, examination of 
induced sputum is potentially a rapid, non-invasive 
method of diagnosing P. carinii pneumonia in 
patients with acquired immunodeficiency syndrome 
(AIDS) (2,3). 
The PCR method can be used for the diagnosis of 
infectious diseases because it enables the detection of 
pathogen DNA in very small quantities of specimens 
in a short time. Recently, it has been reported that 
the diagnosis of P. carinii pneumonia by the PCR 
method using bronchoalveolar lavage (BAL) and 
sputum samples is highly sensitive and specific com- 
pared to conventional diagnostic methods (46). 
However, BAL is not a trivial examination in severe 
respiratory failure and the cough in P. carinii pneu- 
monia is almost always non-productive. Thus, this 
study attempted to detect P. carinii DNA by the PCR 
method in serum, which is easily obtained and widely 
applicable, to establish a non-invasive diagnostic 
method for the identification of P. carinii pneumonia. 
It has been reported that P. carinii DNA was 
present in the serum of P. carinii-infected rodents 
and in the serum of AIDS patients with P. carinii 
pneumonia (9). Sepkowitz et al. reported that PCR 
assay for the P. carinii dihydrofolate reductase gene 
is equally applicable to human pneumocytosis and 
capable of detecting P. carinii both in BAL fluid and 
in the serum of AIDS patients with active P. carinii 
pneumonia (12). They also examined the relationship 
between P. carinii DNA in serum and P. carinii 
infection using the corticosteroid-treated rat model of 
pneumocytosis, and demonstrated that P. carinii 
DNA was detected in rat lungs by 4 weeks of 
immunosuppression, and in their serum by 6 weeks 
(12). However, it has also been reported that PCR 
did not detect P. carinii in blood, or sera (13). 
In the present study, there appears to be a high 
degree of association between active P. carinii pneu- 
monia and the presence of P. carinii DNA in the 
serum. These results suggest that serum PCR for P. 
carinii may be useful as a diagnostic procedure in some 
patients with suspected P. carinii infection. This would 
be of particular value because current diagnosis of P. 
carinii pneumonia frequently requires an invasive pro- 
cedure such as bronchoscopy to obtain respiratory 
specimens for direct microscopic examination. 
The pathogenetic significance of the detection of 
P. carinii DNA or circulating antigens has not yet 
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been established. However, the reported occurrence 
of extrapulmonary pneumocytosis (14) suggests that 
in some patients, P. carinii may have a blood-borne 
phase. Evidence by DNA amplification that P. carinii 
may be blood-borne offers important information 
concerning the natural history of this infection and 
would readily explain the pathogenesis of extra- 
pulmonary pneumocytosis. 
The results of the present study indicate that the 
detection of P. carinii DNA from serum by PCR can 
be used for diagnosis of P. carinii pneumonia. 
Although false-positive results by PCR should be 
considered, because of the repeated PCR positivity of 
these samples and the presence of several negative 
controls at each step of digestion and amplification, it 
is not believed that these specimens represent false- 
positives due to cross-contamination. To monitor 
P. carinii DNA in serum, especially in immunocom- 
promised patients, the PCR method seems to be 
useful for confirming the existence of P. carinii 
infection. 
It is concluded that the detection of P. carirzii DNA 
from serum by PCR amplification provides a valu- 
able tool for rapid diagnosis and early treatment of 
P. carinii pneumonia, and may obviate the need for 
invasive examination. 
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